Who are Placebo capsule (Vitamin K1)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Daily Vitamin D3, Liquid Vitamin D, Vitamin D pill supplementation, Vitamin D3 as "BABY D3", Vitamin D supplement.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-capsule-vitamin-k1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Placebo capsule (Vitamin K1) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Placebo capsule (Vitamin K1) (Placebo capsule (Vitamin K1)) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin/Nutritional supplement. Area: Hematology/Coagulation.

phase 3 Vitamin/Nutritional supplement Gamma-glutamyl carboxylase (GGCX) Hematology/Coagulation Small molecule Live · refreshed every 30 min

Target snapshot

Placebo capsule (Vitamin K1) (Placebo capsule (Vitamin K1)) — University of Sydney. Vitamin K1 acts as a cofactor for gamma-glutamyl carboxylase, enabling the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) and other regulatory proteins.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Placebo capsule (Vitamin K1) TARGET	Placebo capsule (Vitamin K1)	University of Sydney	phase 3	Vitamin/Nutritional supplement	Gamma-glutamyl carboxylase (GGCX)
Daily Vitamin D3	Daily Vitamin D3	Medical University of South Carolina	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Liquid Vitamin D	Liquid Vitamin D	University of California, San Francisco	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Vitamin D pill supplementation	Vitamin D pill supplementation	CHU de Quebec-Universite Laval	marketed	Vitamin/nutritional supplement	Vitamin D receptor (VDR)
Vitamin D3 as "BABY D3"	Vitamin D3 as "BABY D3"	Rambam Health Care Campus	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)
Vitamin D supplement	Vitamin D supplement	Aga Khan University	marketed	Vitamin/Nutritional supplement	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin/Nutritional supplement class)

Aga Khan University · 1 drug in this class
Rambam Health Care Campus · 1 drug in this class
University of Sydney · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo capsule (Vitamin K1) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-capsule-vitamin-k1. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab